What I love about this company is that they have legitimate options to treat both bacteria and viral illnesses across the board, and there are so few available shares that the share price could easily be on par with CSL (or higher) in a few years.
Making a vaccine and cashing in on the massive profit margin sales year after year, regardless of whether the virus actually mutates or they just say it does, might drive people - especially those suffering from financial hardship - to opt out of a yearly vaccine and just take the medicine they need to kill the virus when they get it?
Plus, people who weren't antivax before are becoming that way because of these rushed vaccines and unknown side effects. Who's to say a vaccine that works now doesn't cause everyone who takes it to have a stroke 3 years later?
RCE Price at posting:
$1.49 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)